Anti-HSV-1 herpes vaccination by LUPIDON H: preliminary results.
De Maria
A
A
Department of Infectious Diseases, S. Caterina Novella Hospital, Galatina (Lecce), Italy.
Tundo
P
P
Romano
A
A
Grima
P
P
D000212:Acyclovir / Q000627:therapeutic use; D000293:Adolescent; D000328:Adult; D018791:CD4 Lymphocyte Count; D002648:Child; D003131:Combined Modality Therapy; D005260:Female; D006561:Herpes Simplex / Q000188:drug therapy / Q000276:immunology / Q000628:therapy*; D018259:Herpesvirus 1, Human / Q000276:immunology*; D006801:Humans; D007111:Immunity, Cellular; D016849:Keratitis, Herpetic / Q000188:drug therapy / Q000276:immunology / Q000628:therapy; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D013283:Stomatitis, Herpetic / Q000188:drug therapy / Q000276:immunology / Q000628:therapy; D015164:Vaccines, Inactivated / Q000008:administration & dosage / Q000627:therapeutic use; D014765:Viral Vaccines / Q000008:administration & dosage / Q000627:therapeutic use*
D015164:Vaccines, Inactivated; D014765:Viral Vaccines; D000212:Acyclovir